## **United Health (UH) — Viral Pathogen Dossier**

**Designation:** Lyssavirus chimera sylvanis (LCS)  
**Common Name:** Lycan Vector / Lycanthropy  
**Origin:** Andromeda Galaxy  
**Category:** Cross-species Morphogenic Virus  
**Infection Scope:** All Animalia; morphogenic effects limited to Chordata  
**Status:** Permanent, No Known Cure  
**UH Classification:** Level 4 Interstellar Biohazard — Morphogenic Vector

---

### **1. Overview**

Lyssavirus chimera sylvanis is an engineered viral pathogen created by the radical fey eco-collective, **The Verdant Reclaimers**, as a targeted ecological correction tool. The virus induces controlled physiological transformations in Chordate hosts under lunar illumination, enforcing aggression modulation and phenotype expression from donor species.

LCS is **not magical**; its effects arise from highly advanced bioengineering—termed _biotecture_—leveraging viral overlays on host gene expression, epigenetic programming, and photoresponsive protein complexes.

---

### **2. Host Range and Transmission**

**Host Organisms:**

- **Primary Morphogenic Hosts:** Humanoids, other Chordates.
    
- **Carrier Hosts:** All Animalia. Invertebrates serve solely as viral reservoirs without expressing morphogenic traits.
    

**Transmission Vectors:**

- Direct contact with infected bodily fluids (saliva, blood, etc.)
    
- Bite trauma or wound contamination
    
- Indirect vectors: parasitic arthropods, environmental surfaces, interplanetary fauna transfer
    

**Mechanism:**

- Virus integrates into host cells without replacing the genome.
    
- Epigenetic viral templates overlay host gene expression to trigger species-specific morphogenesis.
    
- Morphogenic activation is lunar-spectrum dependent via cryptochrome-like photoresponsive proteins.
    

---

### **3. Pathophysiology**

**Normal Infection (Non-humanoids):** Minimal outward symptoms; carriers maintain viral load for decades with stable genomic integrity.

**Humanoid Infection:**

- **Initial Exposure:** Flu-like symptoms, heightened sensory acuity, subtle behavioral changes.
    
- **Moonlight Activation:** Involuntary transformation into donor species; range of effects:
    
    - Full Morphosis: Complete transformation into donor-animal phenotype
        
    - Partial Morphosis / Theriocephaly: Retention of animal head or other hybrid features while body remains humanoid
        
    - Permanent Hybridization: Stabilized blending of donor species and humanoid physiology
        
- **Behavioral Effects:** Programmed aggression towards Homo species during lunar cycles; heightened predator instincts
    
- **Long-Term Adaptation:** Neural and stem cell niches harbor virus indefinitely; virus self-repairs and resists mutational drift
    

---

### **4. Clinical Features**

|Feature|Observation|
|---|---|
|Morphogenic Trigger|Lunar-spectrum photons; predictable periodicity|
|Aggression Modulation|Directed against Homo species during moonlight|
|Physiological Changes|Enhanced musculature, sensory amplification, altered reflex patterns|
|Permanence|Viral integration irreversible; no known antiviral therapy effective|
|Complications|Hybridized phenotypes; neural rewiring prevents restoration of original physiology|

---

### **5. Galactic Epidemiology**

- **Andromeda Origins:** Engineered by Verdant Reclaimers as ecological enforcement vector.
    
- **Spread Mechanisms:** Migratory fauna, interstellar animal trade, environmental contamination.
    
- **Current Reach:** Multi-galactic; stable in planetary ecosystems with megafauna.
    
- **Mutation Rate:** Minimal due to viral self-correction and thaumaturgically constrained nucleotide structures.
    

---

### **6. Containment and Management (UH Protocols)**

**Infectee Management:**

- Quarantine for monitoring morphogenic activity
    
- Behavioral therapy to mitigate aggression under lunar activation
    
- Physiological support for hybridized or partially transformed hosts
    

**Carrier Management:**

- Tracking of animal reservoirs
    
- Periodic viral load assessments in multi-species populations
    
- Environmental intervention to reduce transmission vectors
    

**Treatment Outlook:**

- **No curative therapy exists.**
    
- Symptomatic relief, containment, and risk management are primary strategies.
    
- Experimental gene-editing or neural rewiring remains theoretical; extreme risk of lethality.
    

---

### **7. Notes and Observations**

- LCS represents a unique intersection of biology, ecology, and social engineering.
    
- Permanent hybridization events contribute to folklore and urban legends across planetary populations.
    
- LCS highlights the ethical complexities of deploying ecological bioweapons with sentient impact.
    
- UH maintains classified internal studies on cross-species adaptation, lunar activation mechanisms, and epigenetic stability to anticipate multi-galactic epidemiological trends.
    

---

### **8. UH Strategic Classification**

**Level 4 Interstellar Biohazard** – High containment, cross-species implications, irreversible effects, multi-galactic spread.

**Philosophical Note:** _“Lycanthropy is not a curse; it is a relic of biotecture, a shadow of ecological ambition.”_